Emergent BioSolutions
EBS
#7398
Rank
NZ$0.72 B
Marketcap
NZ$13.59
Share price
-26.58%
Change (1 day)
8.29%
Change (1 year)

EPS for Emergent BioSolutions (EBS)

EPS in 2025 (TTM): NZ$2.47

According to Emergent BioSolutions 's latest financial reports the company's current EPS (TTM) is NZ$2.35. In 2024 the company made an earnings per share (EPS) of NZ-$6.05 an increase over its 2023 EPS that were of NZ-$24.81.

EPS history for Emergent BioSolutions from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$2.47-140.84%
2024NZ-$6.05-75.61%
2023NZ-$24.81232.21%
2022NZ-$7.47-203.46%
2021NZ$7.22-25.09%
2020NZ$9.64445.28%
2019NZ$1.77-15.2%
2018NZ$2.08-35.9%
2017NZ$3.2569.57%
2016NZ$1.92-27.67%
2015NZ$2.6565.62%
2014NZ$1.6011.63%
2013NZ$1.4332.31%
2012NZ$1.08

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.27-3.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.18 418.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.28 167.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
NZ-$5.40-329.79%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
NZ$0.70-70.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$5.63-339.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.07-12.06%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel